Biogen Extends License to Linguamatics for Text Search and Mining
News Jun 13, 2006
I2E has been deployed at Biogen Idec since early 2005 and is used by the library and information systems team to solve a diverse range of knowledge discovery problems across the business, in areas such as biomarker discovery, protein-disease associations and toxicology.
The technology is designed to enable the discovery of key information from large collections of text documents that would be impossible or prohibitively time-consuming to find using conventional methods.
The system's linguistic capabilities can be used interactively to extract relevant facts and relationships from unstructured text documents and present them to the user in a structured form.
Commenting on the relationship, Roger Hale, COO of Linguamatics, said, "We are delighted that Biogen Idec have chosen to extend their license."
"This confirms that I2E continues to offer exceptional performance and value across an increasing range of key application areas in the Pharmaceutical and Biotechnology industries."
XenoGesis and BioAscent Forge Alliance to Offer Enhanced Integrated Drug Discovery ServicesNews
XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services, including medicinal chemistry, biology and DMPK.READ MORE
BioAscent Establishes Integrated Drug Discovery Services OfferingNews
Dr Phil Jones to join as new CSO to lead company’s extended capabilities in medicinal chemistry and in vitro biosciences.READ MORE
Lab Innovations returns to the NEC, Bimingham , UKNews
Save the date for the UK’s only lab-dedicated exhibition showcase!READ MORE
Comments | 0 ADD COMMENT
International Conference on Biobetters and Regulatory Affairs
Jun 27 - Jun 28, 2018